| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Sep―09 |
Prevalence of COVID-19 in patients with parkinson’s disease and the impact of parkinson’s disease on COVID-19 prognosis |
Demet Yildiz, Nilüfer Büyükkoyuncu Pekel, Melih Yüksel, Aksel özdemir, Ebru çetin kenan, Muhammed Furkan öztürkci |
| 2 |
[GO] |
2024―Aug―12 |
Acquired idiopathic generalized anhidrosis (AIGA) associated with SARS-CoV-2 infection |
Hye Ryung Kwon, Dae Woong Bae, Jae Young An |
| 3 |
[GO] |
2024―Apr―15 |
A retrospective cohort study: is COVID-19 BNT162b2 mRNA vaccination a trigger factor for cluster headache? |
Suna Aşkın Turan, Şenay Aydın |
| 4 |
[GO] |
2024―Jan―13 |
Living with facioscapulohumeral muscular dystrophy during the first two COVID-19 outbreaks: a repeated patient survey in the Netherlands |
Johanna C. W. Deenen, Joost Kools, Anna Greco, Renée Thewissen, Wiecke van de Put, Anke Lanser, Leo A. B. Joosten, Andre L. M. Verbeek, Baziel G. M. van Engelen, Nicol C. Voermans |
| 5 |
[GO] |
2023―Nov―14 |
Potential beneficial effect of IFN-β1a and ocrelizumab in people with MS during the COVID-19 pandemic |
Stefan Todorović, Slobodan Vojinović, Dejan Savić, Dejan Aleksić, Miloš Danilović |
| 6 |
[GO] |
2023―Sep―05 |
Spectrum of various CNS inflammatory demyelination diseases following COVID-19 vaccinations |
Manish Salunkhe, Kamlesh Tayade, Megha Priyadarshi, Vinay Goel, Isha Gulati, Ajay Garg, Rohit Bhatia, M. V. Padma Srivastava |
| 7 |
[GO] |
2023―Jul―19 |
Miller Fischer syndrome after COVID-19 infection and vaccine: a systematic review |
Panayiota Neophytou, Artemios Artemiadis, Georgios M. Hadjigeorgiou, Panagiotis Zis |
| 8 |
[GO] |
2023―Jul―11 |
Correspondence on COVID-19 vaccination uptake in people with multiple sclerosis |
Amnuay Kleebayoon, Viroj Wiwanitkit |
| 9 |
[GO] |
2023―Jul―04 |
Secondary progressive COVID-19-associated extensive leukoencephalopathy |
Shugang Cao, Minqiang Bao, Rongfeng Wang, Mingwu Xia |
| 10 |
[GO] |
2023―Jun―01 |
COVID-19 vaccination uptake in people with multiple sclerosis compared to the general population |
Dijana Mayer, Barbara Barun, Karla Lazibat, Slava Lasić, Ivan Adamec, Tereza Gabelić, Magdalena Krbot Skorić, Mario Habek |
| 11 |
[GO] |
2023―Mai―25 |
The functional and structural changes in the hippocampus of COVID-19 patients |
Ali Nouraeinejad |
| 12 |
[GO] |
2023―Mrz―20 |
Response to: Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination |
Sohyeon Kim, Minsung Kang, Jin-Sung Park, Hung Youl Seok |
| 13 |
[GO] |
2023―Mrz―03 |
Correspondence on Bell’s palsy as an adverse event following COVID-19 vaccination |
Amnuay Kleebayoon, Viroj Wiwanitkit |
| 14 |
[GO] |
2023―Feb―13 |
Risk and characteristics of Bell’s palsy in adults as an adverse event following COVID-19 vaccination: a retrospective study |
Sohyeon Kim, Minsung Kang, Jin-Sung Park, Hung Youl Seok |
| 15 |
[GO] |
2023―Jan―19 |
Female migraine patients had lower COVID-19 phobia and PCL-5 scores during the lockdown period |
Çile Aktan, Tuğçe Toptan, Çisem Utku, Hayrunnisa Bolay |
| 16 |
[GO] |
2023―Jan―12 |
Patient satisfaction with televisit in chronic neurologic disorders during Covid-19 pandemic |
Irene Rosellini, Marika Vianello, Anna Palmieri, Silvia Vittoria Guidoni, Federico Giopato, Anna Ghazaryan, Matteo Fuccaro, Alberto Terrin, Roberta Vitaliani, Maria Teresa Rigoni, Francesco Pietrobon, Domenico Marco Bonifati |
| 17 |
[GO] |
2022―Dez―16 |
Do prior neurological comorbidities predict COVID-19 severity and death? A 25-month cross-sectional multicenter study on 7370 patients |
Mojtaba Sharafkhah, Farah Moayedi, Nozhan Alimi, Zeinab Haghighi Fini, Mohsen Ebrahimi-Monfared, Ali Massoudifar |
| 18 |
[GO] |
2022―Dez―14 |
Correction to: Clinical characteristics of 365 hospitalized COVID-19 patients with neurological symptoms: an observational study |
Fahimeh Vahabizad, Mansoureh Togha, Shadi Ariyanfar, Mohammad-Reza Fattahi, Samaneh Haghighi, Zahra Ebadi, Sanaz Ahmadi Karvigh, Sara Heidari, Maryam Shafaei, Hale Ashraf, Azar Haddadi, Mohammad Talebpour, Arash Safaei, Hoda Asefi |
| 19 |
[GO] |
2022―Dez―07 |
Triggers and clinical changes of childhood primary headache characteristics during COVID-19 pandemic lockdown |
Özge Dedeoglu, Bahadır Konuşkan |
| 20 |
[GO] |
2022―Nov―22 |
Diagnostic challenges of functional neurological disorders after covid-19 disease or vaccination: case series and review of the literature |
Sergiu Albu, Margarita Vallès, Hatice Kumru |
| 21 |
[GO] |
2022―Nov―16 |
COVID-19 and Parkinson’s disease: a systematic review and meta-analysis |
Maryam Afraie, Ghobad Moradi, Pardis Mohammadzedeh, Mobin Azami, Sevda Riyahifar, Yousef Moradi |
| 22 |
[GO] |
2022―Nov―16 |
A review of the potential neurological adverse events of COVID-19 vaccines |
Zeinab Mohseni Afshar, Akanksha Sharma, Arefeh Babazadeh, Ali Alizadeh-Khatir, Terence T. Sio, Mohamad Ali Taghizadeh Moghadam, Ali Tavakolli Pirzaman, Ahmadreza Mojadad, Rezvan Hosseinzadeh, Mohammad Barary, Soheil Ebrahimpour |
| 23 |
[GO] |
2022―Nov―04 |
Immune responses following COVID-19 infection in multiple sclerosis patients using immunomodulatory therapy |
Nuray Bilge, Fatma Kesmez Can, Recep Yevgi |
| 24 |
[GO] |
2022―Okt―24 |
COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis |
Stojan Peric, Milos Rankovic, Ivo Bozovic, Vanja Radosavljevic, Ivan Marjanovic, Ivana Basta, Dragana Lavrnic |
| 25 |
[GO] |
2022―Okt―22 |
Study of sympathetic skin response in patients with COVID-19 infection |
Sharareh Roshanzamir, Leila Sadat Mohamadi Jahromi |
| 26 |
[GO] |
2022―Okt―22 |
Comment on “Neuromuscular complications after COVID-19 vaccination: a series of eight patients” by Leemans et al. |
Giuliana Galassi, Alessandra Ariatti |
| 27 |
[GO] |
2022―Aug―25 |
Clinical characteristics of 365 hospitalized COVID-19 patients with neurological symptoms: an observational study |
Fahimeh Vahabizad, Mansoureh Togha, Shadi Arianfar, Mohammad-Reza Fattahi, Samaneh Haghighi, Zahra Ebadi, Sanaz Ahmadi Karvigh, Sara Heidari, Maryam Shafaei, Hale Ashraf, Azar Haddadi, Mohammad Talebpour, Arash Safaei, Hoda Asefi |
| 28 |
[GO] |
2022―Aug―02 |
Epidemiology, clinical features, and treatment modalities of facial nerve palsy in COVID-19 patients: a systematic review |
Aya Turki, Kirellos Said Abbas, Abdelrahman M Makram, Mostafa Elfert, Mahmoud Elmarabea, Nahla Ahmed El-Shahat, Hassan Abdalshafy, Akua Sampong, Sirisha Chintalapati, Nguyen Tien Huy |
| 29 |
[GO] |
2022―Jul―30 |
Seizures in COVID-19: the relationship between biomarkers and prognosis |
Pınar Bengi Boz, Kezban Aslan-Kara, Zeynep Selcan Şanlı, Mehmet Taylan Peköz, Dilek Acar, Hacer Bozdemir |
| 30 |
[GO] |
2022―Jul―14 |
Opsoclonus myoclonus ataxia syndrome following COVID-19 infection |
Ismail Ibrahim Ismail, Walaa A. Kamel, Ayman Kilany |
| 31 |
[GO] |
2022―Jul―07 |
A questionnaire-based survey of acceptability and satisfaction of virtual neurology clinic during COVID-19 lockdown: a preliminary study |
Anand Kumar, Neha Lall, Abhishek Pathak, Deepika Joshi, Vijaya Nath Mishra, Rameshwar Nath Chaurasia, Varun Kumar Singh |
| 32 |
[GO] |
2022―Jun―26 |
Evaluation of cognitive, mental, and sleep patterns of post-acute COVID-19 patients and their correlation with thorax CT |
Ömer Faruk Bolattürk, Akın Cem Soylu |
| 33 |
[GO] |
2022―Jun―25 |
Alexia without agraphia in an elderly man due to stroke secondary to COVID-19 infection |
Faheem Arshad, Vikram Singh, Chandrajit Prasad, Ravi Yadav, Suvarna Alladi |
| 34 |
[GO] |
2022―Jun―20 |
A case of transient POTS following COVID-19 vaccine |
Jeonghyun Park, Sanghyun Kim, Jusuck Lee, Jae Young An |
| 35 |
[GO] |
2022―Jun―12 |
Eotaxin-1 (CCL11) in neuroinflammatory disorders and possible role in COVID-19 neurologic complications |
Donya Nazarinia, Mahin Behzadifard, Javad Gholampour, Roqaye Karimi, Mohammadali Gholampour |
| 36 |
[GO] |
2022―Jun―07 |
The relevance of headache as an onset symptom in COVID-19: a network analysis of data from the LONG-COVID-EXP-CM multicentre study |
César Fernández-de-las-Peñas, Umut Varol, Víctor Gómez-Mayordomo, María L. Cuadrado, Juan Antonio Valera-Calero |
| 37 |
[GO] |
2022―Mai―26 |
Long-term evaluation of the COVID-19 pandemic impact on acute stroke management: an analysis of the 21-month data from a medical facility in Tokyo |
Takashi Mitsuhashi, Joji Tokugawa, Hitoshi Mitsuhashi |
| 38 |
[GO] |
2022―Mai―02 |
Human herpes 6 encephalitis in co-infection with Covid-19 |
A. Di Nora, F. Pizzo, G. Costanza, M. Ruggieri, R. Falsaperla |
| 39 |
[GO] |
2022―Mai―02 |
Neuromuscular complications after COVID-19 vaccination: a series of eight patients |
Wouter Leemans, Sofie Antonis, Wouter De Vooght, Robin Lemmens, Philip Van Damme |
| 40 |
[GO] |
2022―Mrz―13 |
Post-acute COVID-19 syndrome presented as a cerebral and systemic vasculitis: a case report |
Jovana Ivanovic, Maja Stojanovic, Aleksandar Ristic, Dragoslav Sokic, Nikola Vojvodic |
| 41 |
[GO] |
2022―Mrz―03 |
Autonomic dysfunction in patients with COVID-19 |
Yuksel Erdal, Arife Cimen Atalar, Taskın Gunes, Tugba Okluoglu, Nurettin Yavuz, Ufuk Emre |
| 42 |
[GO] |
2022―Feb―22 |
Acute akinetic-rigid syndrome in COVID-19 encephalitis |
Boby Varkey Maramattom, Asha Kishore |
| 43 |
[GO] |
2022―Feb―19 |
COVID-19-booster vaccine-induced encephalitis |
Yasmine Sluyts, Yuna Arnst, Toon Vanhemelryck, Harald De Cauwer |
| 44 |
[GO] |
2022―Feb―17 |
A telephonic survey of health-related quality of life of outpatient department dropout Parkinson’s disease patients during the COVID-19 pandemic |
Atul Goel, Sunil K. Narayan, Ramkumar Sugumaran |
| 45 |
[GO] |
2022―Jan―31 |
Acute haemorrhagic necrotizing encephalopathy in the setting of SARS-CoV-2 vaccination: a case report and literature review |
Pakeeran Siriratnam, Katherine Buzzard, Gary Yip |
| 46 |
[GO] |
2022―Jan―30 |
Telemedicine as a strategic intervention for cognitive rehabilitation in MS patients during COVID-19 |
Fereshteh Ghadiri, Abdorreza Naser Moghadasi, Mohammad Ali Sahraian |
| 47 |
[GO] |
2022―Jan―22 |
Three territory sign in COVID-19 |
Prashant Bhatele, Animesh Das, Awadh Kishor Pandit, Divya M. Radhakrishnan, Achal Kumar Srivastava |
| 48 |
[GO] |
2022―Jan―21 |
Neurological manifestations as prognostic factors in COVID-19: a retrospective cohort study |
Pedro Augusto Sampaio Rocha-Filho, João Eudes Magalhães, Djanino Fernandes Silva, Miriam Carvalho Soares, Lucas Marenga Arruda Buarque, Mylana Dandara Pereira Gama, Felipe Araújo Andrade Oliveira |
| 49 |
[GO] |
2022―Jan―16 |
Impact of the COVID-19 outbreak on neurological consultation in an emergency department |
Milan Maretta, Matej Škorvánek, Veronika Jurková, Norbert Leško, Zuzana Gdovinová |
| 50 |
[GO] |
2022―Jan―15 |
Correction to: Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine |
Gulay Ozgen Kenangil, Buse Cagla Ari, Cagan Guler, Mustafa Kemal Demir |
| 51 |
[GO] |
2022―Jan―10 |
Analysis of neurology consultations in hospitalized patients with COVID-19 |
Merve Hazal Ser, Uygur Tanrıverdi, Çiğdem Özkara, Sabahattin Saip, Ceren Aliş, Zeynep Ece Kaya Güleç, Gözde Nezir, Esra Koçhan Kızılkılıç, Merve Aktan Süzgün, Hikmet Abbaszade, Şermin Börekçi, Rıdvan Karaali, Osman Kızılkılıç, Ayşegül Gündüz, Feray Karaali Savrun |
| 52 |
[GO] |
2021―Nov―24 |
Mucormycosis in COVID-19 patients: predisposing factors, prevention and management |
Pavan Kumar Rudrabhatla, Aravind Reghukumar, Sanjeev V. Thomas |
| 53 |
[GO] |
2021―Nov―12 |
Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report |
Fabio Giuseppe Masuccio, Cristoforo Comi, Claudio Solaro |
| 54 |
[GO] |
2021―Okt―11 |
Isolated intracranial hypertension following SARS-CoV-2 infection in an adolescent boy: a case report |
Alaa ELmazny, Shireen Mostafa Shousha, Samira Saraya, Rehab Magdy |
| 55 |
[GO] |
2021―Okt―05 |
Comment on case series of COVID-19 in patients with myasthenia gravis: a single institution experience by Županić et al. |
Giuliana Galassi, Alessandro Marchioni |
| 56 |
[GO] |
2021―Okt―01 |
Guillain-Barré syndrome following Covid-19 immunization: a report of two cases |
Francesco Bax, Gian Luigi Gigli, Enrico Belgrado, Laura Brunelli, Mariarosaria Valente |
| 57 |
[GO] |
2021―Sep―29 |
Teleneurology in a center for neuromuscular diseases during the COVID-19 pandemic |
Kanellos C. Spiliopoulos, Nikolaos Kasdaglis, Dimitra Veltsista, Dimosthenis Lykouras, Maria Lagadinou, Elisabeth Chroni |
| 58 |
[GO] |
2021―Sep―16 |
Asymptomatic infection after BNT162b2 mRNA COVID-19 vaccination in multiple sclerosis patient |
Dejan Jakimovski, Bianca Weinstock-Guttman |
| 59 |
[GO] |
2021―Sep―03 |
SARS-CoV-2-associated Guillain-Barré syndrome in four patients: what do we know about pathophysiology? |
Antoine Guilmot, Sofia Maldonado Slootjes, Véronique Bissay, Nicolas Dubuisson, Clémence de Broglie, Michel Gille |
| 60 |
[GO] |
2021―Aug―24 |
From influenza to SARS-CoV-2: etiological evaluation of acute benign childhood myositis |
Emine Tekin, Handan Ayhan Akoğlu |
| 61 |
[GO] |
2021―Jul―29 |
Is there a common pathophysiological mechanism between COVID-19 and depression? |
Luciano da Silva Lopes, Raquel Oliveira Silva, Guilherme de Sousa Lima, Arthur Caminha de Araújo Costa, Daniela França Barros, Raimundo Pereira Silva-Néto |
| 62 |
[GO] |
2021―Jul―01 |
Lockdown effects on Parkinson’s disease during COVID-19 pandemic: a pilot study |
Marika Falla, Alessandra Dodich, Costanza Papagno, Alessandro Gober, Pamela Narduzzi, Enrica Pierotti, Markus Falk, Francesca Zappini, Carlo Colosimo, Luca Turella |
| 63 |
[GO] |
2021―Jun―19 |
The impact of COVID-19 on acute stroke care in Belgium |
Vincent Raymaekers, Jelle Demeestere, Flavio Bellante, Sofie De Blauwe, Sylvie De Raedt, Anne Dusart, Lise Jodaitis, Robin Lemmens, Caroline Loos, Ligot Noémie, Matthieu P. Rutgers, Fenne Vandervorst, Geert Vanhooren, Laetitia Yperzeele, Raul G. Nogueira, Thanh N. Nguyen, Peter Vanacker |
| 64 |
[GO] |
2021―Jun―03 |
A case report of Guillain-Barré syndrome in a pregnant woman infected by COVID-19 |
Masoud Mehrpour, Maliheh Arab, Fahimeh Hadavand, Mahdiyeh Khalafi, Mohammad Khalafi |
| 65 |
[GO] |
2021―Mai―20 |
Acute disseminated encephalomyelitis-like presentation after an inactivated coronavirus vaccine |
Gulay Ozgen Kenangil, Buse Cagla Ari, Cagan Guler, Mustafa Kemal Demir |
| 66 |
[GO] |
2021―Mai―05 |
Neurological diseases and COVID-19: prospective analyses using the UK Biobank |
Nicola Veronese, Lee Smith, Mario Barbagallo, Gianluigi Giannelli, Maria Gabriella Caruso, Anna Maria Cisternino, Maria Notarnicola, Chao Cao, Thomas Waldhoer, Lin Yang |
| 67 |
[GO] |
2021―Mai―03 |
Demyelination as a result of an immune response in patients with COVID-19 |
Zahra Shabani |
| 68 |
[GO] |
2021―Apr―21 |
Investigating the effects of the COVID-19 pandemic on the reasons for application to the emergency department in patients with neurological symptoms |
Cemile Haki, Halil Kaya |
| 69 |
[GO] |
2021―Apr―05 |
Bilateral peripheral facial palsy following asymptomatic COVID-19 infection: a case report |
Jeroen Kerstens, Lien Deschuytere, Katlijn Schotsmans, Emke Maréchal |
| 70 |
[GO] |
2021―Apr―02 |
Myasthenia gravis at the crossroad of COVID-19: focus on immunological and respiratory interplay |
Giuliana Galassi, Alessandro Marchioni |
| 71 |
[GO] |
2021―Apr―01 |
Case series of COVID-19 in patients with myasthenia gravis: a single institution experience |
Sven Županić, Martina Perić Šitum, Maja Majdak, Mirna Karakaš, Silvio Bašić, Davor Sporiš |
| 72 |
[GO] |
2021―Mrz―02 |
Letter to Editor: Collateral damage: impact of COVID-19 on stroke care in three downtown Los Angeles Community Hospitals |
Diana Escobar, Cara Beth Rogers, Ian Christensen, Michael Jordan, Antonio Liu |
| 73 |
[GO] |
2021―Feb―09 |
The effects of coronavirus disease 2019 (COVID-19) pandemic on people with epilepsy (PwE): an online survey-based study |
Fathi Abokalawa, Samar Farouk Ahmad, Jasem Al-Hashel, Ahmed Medhat Hassan, Maher Arabi |
| 74 |
[GO] |
2021―Feb―02 |
Optic neuropathy in a patient with COVID-19 infection |
Patricia Rodrigo-Armenteros, Juan María Uterga-Valiente, Juncal Zabala-Del-Arco, Silvia Taramundi-Argüeso, Lander Antón-Méndez, Juan José Gómez-Muga, Juan Carlos Garcia-Monco |
| 75 |
[GO] |
2021―Feb―01 |
Acute disseminated encephalomyelitis after severe acute respiratory syndrome coronavirus 2 vaccination: a case report |
Liming Cao, Lijie Ren |
| 76 |
[GO] |
2021―Jan―19 |
SARS-CoV-2: its potential neurological manifestations and plausible mechanism: a review article |
Tasneem Taher, Anum Bilal Sheikh, Farah Anwar, Faisal Khosa |
| 77 |
[GO] |
2021―Jan―03 |
Deep cerebral venous sinus thrombosis with transient antiphospholipid antibodies in COVID-19 disease |
C. M. J. Loos, L. Yperzeele, C. Jadoul, I. Baar, P. G. Jorens |
| 78 |
[GO] |
2020―Nov―24 |
Susac syndrome following COVID-19 infection |
Laura Venditti, Antoine Rousseau, Claire Ancelet, Thomas Papo, Christian Denier |
| 79 |
[GO] |
2020―Nov―23 |
Myotoxic drugs and immunodeficiency may contribute to the poor outcome of COVID-19 patients with myotonic dystrophy |
J. Finsterer |
| 80 |
[GO] |
2020―Nov―16 |
Be aware: COVID-19 the new stroke mimicker |
Susanna M. Zuurbier, Hanne-Laure Verschelde, Soetkin Vantyghem, Laetitia Yperzeele, Peter Vanacker |
| 81 |
[GO] |
2020―Okt―14 |
Myotonic dystrophy type 1 as a major risk factor for severe COVID-19? |
Sebastiaan Dhont, Rutger Callens, Dieter Stevens, Fre Bauters, Jan L. De Bleecker, Eric Derom, Eva Van Braeckel |
| 82 |
[GO] |
2020―Sep―18 |
Post COVID-19 longitudinally extensive transverse myelitis (LETM)-a case report |
Seyed Mohammad Baghbanian, Farzaneh Namazi |
| 83 |
[GO] |
2020―Aug―10 |
Letter to the Editor: Neurohospitalist and COVID-19 |
Lisa Duong, Prissilla Xu, Jonathan Eskenazi, Antonio Liu |
| 84 |
[GO] |
2020―Jul―21 |
Facing acute neuromuscular diseases during COVID-19 pandemic: focus on Guillain-Barré syndrome |
Giuliana Galassi, Alessandro Marchioni |
| 85 |
[GO] |
2020―Jul―21 |
Correction to: Neurological manifestations of COVID-19, SARS and MERS |
Kato Verstrepen, Laure Baisier, Harald De Cauwer |
| 86 |
[GO] |
2020―Jul―07 |
Acute stroke care during the COVID-19 pandemic: difficult, but not impossible! |
Sofia Maldonado Slootjes, Frank Hammer, Jonathan Leempoel, André Peeters |
| 87 |
[GO] |
2020―Jun―19 |
Neurological manifestations of COVID-19, SARS and MERS |
Verstrepen Kato, Baisier Laure, De Cauwer Harald |
| 88 |
[GO] |
2020―Jun―10 |
A complication of coronavirus disease 2019: delirium |
Gabriele Cipriani, Sabrina Danti, Angelo Nuti, Cecilia Carlesi, Claudio Lucetti, Mario Di Fiorino |
| 89 |
[GO] |
2020―Mai―22 |
Are patients with Down syndrome vulnerable to life-threatening COVID-19? |
Harald De Cauwer, Ann Spaepen |
